StonvexLoading…
StonvexStonvexStonvexCore line items from ALKT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $443.64M | $322.85M | $209.89M | $97.83M |
Operating Income | $-53.64M | $-44.14M | $-31.26M | $-15.40M |
Net Income | $-47.65M | $-36.21M | $-21.41M | $-7.82M |
EPS (Diluted) | $-0.46 | $-0.35 | $-0.21 | $-0.08 |
Total Assets | $847.23M | $835.17M | $840.39M | $837.16M |
Total Liabilities | $485.18M | $485.06M | $496.37M | $503.12M |
Cash & Equivalents | $63.46M | $57.32M | $52.43M | $61.66M |
Free Cash Flow OCF − CapEx | $41.36M | $25.14M | $-5.39M | $-6.15M |
Shares Outstanding | 106.10M | 105.00M | 104.08M | 103.02M |